These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28816033)

  • 21. Population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations.
    Spyker DA; Dart RC; Yip L; Reynolds K; Brittain S; Yarema M
    Clin Toxicol (Phila); 2022 Oct; 60(10):1113-1121. PubMed ID: 36106921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and bioavailability of oxycodone and acetaminophen following single-dose administration of MNK-795, a dual-layer biphasic IR/ER combination formulation, under fed and fasted conditions.
    Devarakonda K; Morton T; Margulis R; Giuliani M; Barrett T
    Drug Des Devel Ther; 2014; 8():1125-34. PubMed ID: 25170252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
    Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human abuse potential of immediate-release/extended-release versus immediate-release hydrocodone bitartrate/acetaminophen: a randomized controlled trial in recreational users of prescription opioids.
    Devarakonda K; Kostenbader K; Zheng Y; Montgomery JB; Barrett T; Young JL; Webster LR
    Postgrad Med; 2015 Jan; 127(1):13-21. PubMed ID: 25584931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol.
    Tanner T; Aspley S; Munn A; Thomas T
    BMC Clin Pharmacol; 2010 Jul; 10():10. PubMed ID: 20602760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Tolerability of Biphasic Immediate-Release/Extended-Release Oxycodone/Acetaminophen Tablets: Analysis of 11 Clinical Trials.
    Barrett T; Kostenbader K; Nalamachu S; Giuliani M; Young JL
    Pain Pract; 2016 Sep; 16(7):856-68. PubMed ID: 26296448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration.
    Ishitsubo N; Oguro S; Shimahashi H; Kawanishi M; Adachi T; Mitsuda K; Ishibashi N
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):87-100. PubMed ID: 38064122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacokinetic comparison of acetaminophen products (Tylenol Extended Relief vs regular Tylenol).
    Douglas DR; Sholar JB; Smilkstein MJ
    Acad Emerg Med; 1996 Aug; 3(8):740-4. PubMed ID: 8853667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O; Alvarez JC
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of subjective effects of extended-release versus immediate-release oxycodone/acetaminophen tablets in healthy nondependent recreational users of prescription opioids: a randomized trial.
    Morton T; Kostenbader K; Montgomery J; Devarakonda K; Barrett T; Webster L
    Postgrad Med; 2014 Jul; 126(4):20-32. PubMed ID: 25141240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind, placebo-controlled study of the efficacy and safety of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen tablets for acute postoperative pain.
    Singla N; Margulis R; Kostenbader K; Zheng Y; Barrett T; Giuliani MJ; Chen Y; Young JL
    Phys Sportsmed; 2015 May; 43(2):126-37. PubMed ID: 25796986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of suppository acetaminophen in healthy and hospitalized ill dogs.
    Sikina ER; Bach JF; Lin Z; Gehring R; KuKanich B
    J Vet Pharmacol Ther; 2018 Oct; 41(5):652-658. PubMed ID: 29756216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and Tolerability Comparison of Sustained and Immediate Release Oral Formulations of Nifedipine Tablet Formulations: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Egyptian Male Volunteers.
    El-Masry SM; El-Khodary NM
    Drug Res (Stuttg); 2020 Feb; 70(2-03):91-96. PubMed ID: 31746448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic study on acetaminophen: interaction with a Chinese medicine.
    Qi J; Toyoshima A; Honda Y; Mineshita S
    J Med Dent Sci; 1997 Mar; 44(1):31-5. PubMed ID: 9385040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of acetaminophen sulfate after oral administration in rats: analysis of plasma profiles exhibiting a non-linear second peak.
    Sawamoto T; Kurosaki Y; Kimura T; Nakayama T
    Biol Pharm Bull; 1996 Jan; 19(1):77-82. PubMed ID: 8820916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic Adaptation to Therapeutic Doses of Acetaminophen: An Exploratory Study in Healthy Individuals.
    Maeda M; Tanaka R; Aso M; Sakamoto Y; Song I; Ochiai M; Saito Y; Maekawa K; Arakawa N; Ohno Y; Kumagai Y
    Clin Ther; 2020 Jul; 42(7):1276-1291.e1. PubMed ID: 32620339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel paracetamol 1,000 mg sustained release formulation vs conventional paracetamol 500 mg formulation in patients with fever and pain: a randomized noninferiority trial.
    Ghosh S; Patel J; Patel H; Pandya N; Naik S; Patel H
    Pain Med; 2013 Mar; 14(3):436-41. PubMed ID: 23369038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative bioavailability and plasma paracetamol profiles of Panadol suppositories in children.
    Coulthard KP; Nielson HW; Schroder M; Covino A; Matthews NT; Murray RS; Van Der Walt JH
    J Paediatr Child Health; 1998 Oct; 34(5):425-31. PubMed ID: 9767504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence Evaluation of Two Oral Formulations of Acetaminophen in Healthy Subjects: Results From a Randomized, Single-Blind, Crossover Study.
    García Aguirre L; Bohorquez Nassar C; Ruiz Olmedo I; Dennie L; Medina Nolasco AG
    Clin Pharmacol Drug Dev; 2019 Jan; 8(1):9-15. PubMed ID: 29749718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety profile of sustained release paracetamol during therapeutic use and following overdose.
    Dart RC; Green JL; Bogdan GM
    Drug Saf; 2005; 28(11):1045-56. PubMed ID: 16231956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.